Shares of Adamis Pharmaceuticals Corp. (Nasdaq: ADMP) fell 50 cents to close at $2.97 and Antares Pharmaceuticals Inc. (Nasdaq: ATRS) lost 23 cents to close at $1.18 after Mylan (Nasdaq: MYL) announced plans to offer a generic version of its severe allergic reaction auto-injector treatment EpiPen. Mylan stock rose 19 cents to close at $43.22.
Mylan to offer generic version of EpiPen
August 29, 2016 at 19:22 PM EDT